RCS - Quasar Medical - Quasar Medical Acquires Nordson's Ireland Facility
29/05/2025 13:45
For best results when printing this announcement, please click on link below: https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250529:nRSc5759Ka&default-theme=true RNS Number : 5759K Quasar Medical 29 May 2025 Quasar Medical Will Acquire Nordson MEDICAL Design and Development Business in Galway, Ireland, and Tecate, Mexico Quasar Grows Global Full-Lifecycle CDMO Platform; Nordson MEDICAL Sharpens Focus on Core Components Business SAINT PAUL, MINNESOTA / ACCESS Newswire (https://www.accessnewswire.com/) / May 29, 2025 / Quasar Medical, a global leader in the manufacturing of interventional and complex minimally invasive devices, announced it has signed a definitive agreement with Nordson Corporation (NASDAQ:NDSN) to acquire its design and development contract manufacturing businesses in Galway, Ireland, and Tecate, Mexico. This will strengthen Quasar's global position as a full-service Contract Development and Manufacturing Organization (CDMO), offering end-to-end solutions from initial design to large-scale production. The deal is expected to close in the third quarter of calendar 2025. The Galway and Tecate facilities will be integrated into Quasar's expanding global platform, adding specialized expertise in complex balloon and catheter design, rapid prototyping, and cost-efficient device near-shore assembly. Both sites provide Quasar with not only advanced know-how and IP-generating capabilities but will also add FDA-registered and ISO-certified facilities and a highly skilled workforce located in two strategic MedTech hubs. "This is more than a bolt-on acquisition - it marks the next chapter for Quasar," said Alex Wallstein, CEO of Quasar Medical. "We are now positioned to deliver fully integrated interventional solutions from concept to scale-up finished device, adding significant capacity in Ireland and Mexico to our well-established Asian footprint - diversifying Quasar into a global CDMO partner." Dave Zgonc, Vice President of Nordson MEDICAL Interventional Solutions, said, "We're extremely proud of the highly skilled teams in Galway and Tecate, their expertise, and the customer partnerships they've built over the years in our finished device contract manufacturing business. We are thankful for their commitment and dedication to this business." EXPANDED CAPABILITIES, GLOBAL REACH With this acquisition, Quasar Medical now operates 10 facilities across North America, Europe, Israel, and Asia, providing added expertise in design, development, balloon catheter systems, micro-EM sensors, and rapid scale-up of low-cost assembly and manufacturing. · 800,000 square feet of manufacturing space · Over 4,200 employees, including over 50 NPD Engineers · FDA-registered and ISO 13485 certified · Galway: design, prototyping, and product development, as well as manufacturing · Tecate: cost-effective, scalable device manufacturing and assembly CUSTOMER BENEFITS & STRATEGIC IMPACT Quasar Medical's customers will benefit from: · Integrated design-for-manufacturing and scalable production · Seamless program transfers and faster market readiness · Near-shore operations for U.S. customers · Regionally optimized manufacturing strategies balancing speed, quality, and cost · Robust quality infrastructure with FDA and ISO 13485 compliance across all facilities This strategic step expands Quasar's ability to support global OEMs and innovators with speed, flexibility, innovation, and precision - from concept to prototype to finished device delivery. Quasar will work closely with Nordson to ensure a smooth transition for all customers and suppliers. Upon closing, the Galway and Tecate sites will be fully integrated into the Quasar platform. Quasar Medical is a global Contract Development and Manufacturing Organization (CDMO) delivering end-to-end solutions for interventional and minimally invasive medical devices. With 10 global facilities and 4,200 employees across Asia, North America, and Europe, Quasar specializes in catheter systems, balloon technologies, micro-EM sensors, and complex assemblies. Headquartered in Singapore, the company offers fully integrated device solutions spanning design, prototyping, and scalable manufacturing. Quasar operates under ISO 13485:2016 and cGMP standards, serving leading medical device OEMs and innovators worldwide. For more information, visit www.quasarmedical.com (https://quasarmedical.com/) . Nordson MEDICAL is a global expert in the design, development and manufacturing of medical component technologies and proprietary technologies and devices. Our extensive breadth of solutions serves interventional, surgical and specialized markets with technologies that save or enhance lives. As an integrated partner, Nordson MEDICAL enables customers to save costs and speed time to market. For more information, visit www.nordsonmedical.com (https://www.nordsonmedical.com/) . Nordson Corporation is an innovative precision technology company that leverages a scalable growth framework through an entrepreneurial, division-led organization to deliver top-tier growth with leading margins and returns. The Company's direct sales model and applications expertise serve global customers through a wide variety of critical applications. Its diverse end-market exposure includes consumer non-durable, medical, electronics and industrial end markets. Founded in 1954 and headquartered in Westlake, Ohio, the Company has operations and support offices in over 35 countries. Visit Nordson on the web at nordson.com (https://stats.nwe.io/x/html?final=aHR0cDovL3d3dy5ub3Jkc29uLmNvbS8&sig=fP5ABeDO9f1DuBE_FV46UGDoMMcEBxc1RV9hTem8-zf2l2ZAx6NU1dR_wB1htAhUv2bU0JpcM6kEG326Ma0DUA&hit%2Csum=WyI0eDdkcjMiLCI0eDdkcjQiLCI0eDdkcjIiXQ) , twitter.com/Nordson_Corp (https://stats.nwe.io/x/html?final=aHR0cHM6Ly90d2l0dGVyLmNvbS9Ob3Jkc29uX0NvcnA&sig=k9RI6FmFw8X0jqRn8Oo3BPXdo9Rxn8kJuZhogabKee8wkNu644cbceGQ0nZKJdJBx_v9FQNa_eCoJlj7bXzOeQ&hit%2Csum=WyI0eDdkcjUiLCI0eDdkcjYiLCI0eDdkcjIiXQ) or facebook.com/nordson (https://stats.nwe.io/x/html?final=aHR0cHM6Ly93d3cuZmFjZWJvb2suY29tL25vcmRzb24&sig=wigTVe1M4lUY1qLQKqY_6wAXD6CiJOTXLBPAB_lNYnD87j6-1b65CkF62E-rYVCb9F9Z-NDERkKA-o7YSD-hUQ&hit%2Csum=WyI0eDdkcjciLCI0eDdkcjgiLCI0eDdkcjIiXQ) . Contact Information Jackie Rauchberger Senior Director Global Marketing, Quasar Medical marketingpr@quasar-med.com (651) 641-4034 Lara Mahoney Vice President, Corporate Communications and Investor Relations, Nordson Corporation 440-204-9985 SOURCE: Quasar Medical Related Images This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com (mailto:rns@lseg.com) or visit www.rns.com (http://www.rns.com/) . RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy) . END NRAFIFESEIIAFIE